LAS VEGAS -- Skinvisible, Inc. announces that it has signed a distribution agreement with Canadian-based Clara Laboratories Ltd. granting them the right to distribute, market and sell its patented Antimicrobial Hand Sanitizer lotion and spray formulation through established sub-distributors in China, Singapore, Hong Kong and Macau.
Skinvisible has shipped an initial order of 19 55-gallon drums of the Antimicrobial Hand Sanitizer formulation for the Honk Kong market. Skinvisible expects to ship product both in bulk drums and pre-packaged in order to meet a strong and growing demand for its proprietary formulation within the Asian marketplace. Clara Laboratories has a mandate to represent and promote North American medical technologies within the Asian marketplace and reciprocally represent Asian technologies within North America.
Proven advantages of the Skinvisible formulation include its demonstrated ability to adhere to the skin, forming a protective bond, resisting both wash-off and perspiration while holding the active ingredient Triclosan on the skin for extended periods of time. Independent studies show that the active agent stays on the skin for up to 4 hours per application, maintaining its effectiveness even with frequent hand washings, providing a continuous kill of pathogens tested during that time. Skinvisible's proprietary formulation is alcohol-free, offering distinct advantages over alcohol-based gel sanitizers that typically provide instant protection but offer no long-term persistence, wash-off, and require continuous reapplication, sometimes causing adverse skin reactions.
"Although it is proven to be effective on its own, we specifically designed our sanitizer formulation to be a complementary adjunct to hand washing rather than a replacement," emphasizes Skinvisible's chemist, Dr. James Roszell. "What sets our product apart is not only its ability to bond to the skin and remain effective for extended periods, but also the simultaneous benefit of protecting the skin against the rigors of even frequent hand-washing such as that required to meet medical and food service protocols."
Source: Skinvisible, Inc.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.